HWP
CVS icon

Highline Wealth Partners’s CVS Health CVS Stock Holding History

Highline Wealth Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.1K Buy
542
+188
+53% +$16.8K 0.01% 220
2026
Q1 		$25.4K Buy
354
+10
+3% +$770 0.01% 258
2025
Q4 		$27.3K Buy
344
+7
+2% +$552 0.01% 206
2025
Q3 		$25.4K Buy
337
+18
+6% +$1.23K 0.01% 234
2025
Q2 		$22K Sell
319
-8
-2% -$525 0.01% 214
2025
Q1 		$22.2K Buy
327
+163
+99% +$9.75K 0.01% 199
2024
Q4 		$7.36K Sell
164
-6,425
-98% -$360K ﹤0.01% 285
2024
Q3 		$414K Sell
6,589
-578
-8% -$33.7K 0.14% 81
2024
Q2 		$423K Sell
7,167
-2,434
-25% -$152K 0.16% 77
2024
Q1 		$766K Hold
9,601
– – 0.31% 60
2023
Q4 		$758K Buy
9,601
+5
+0.1% +$356 0.37% 62
2023
Q3 		$670K Buy
9,596
+2,039
+27% +$144K 0.41% 57
2023
Q2 		$522K Sell
7,557
-12
-0.2% -$854 0.33% 70
2023
Q1 		$562K Sell
7,569
-1
-0% -$84 0.38% 63
2022
Q4 		$705K Buy
7,570
+3
+0% +$289 0.52% 55
2022
Q3 		$722K Buy
+7,567
New +$749K 0.59% 44

Other funds holding CVS

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
CAM
Cacti Asset Management Atlanta, Georgia $1.99B AUM 86.33% 1-Year Est. Return

Highline Wealth Partners's CVS Position: Q2 2026 in Review

Highline Wealth Partners increased its CVS Health (CVS) stake by 53% in Q2 2026, buying an estimated $16.8K and bringing the position to 542 shares worth $56.1K. The position accounts for 0.01% of the portfolio, ranked #220.

Highline Wealth Partners first reported a position in CVS in Q3 2022 and has held it in 16 quarters since. The position peaked at $766K in Q1 2024. 399 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Highline Wealth Partners held 542 shares of CVS Health worth $56.1K as of Q2 2026.
  • Highline Wealth Partners bought 188 CVS Health shares in Q2 2026, an estimated $16.8K.
  • CVS Health made up 0.01% of Highline Wealth Partners's portfolio in Q2 2026, its #220 holding.
  • Highline Wealth Partners first reported a position in CVS Health in Q3 2022 and has held it in 16 quarters since.
  • Highline Wealth Partners's CVS Health position peaked at $766K in Q1 2024.
  • 399 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.